(Q60938469)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30622535%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

6 references

28 May 2020

9 September 2020

5 November 2020

8 February 2021

3 May 2021

25 July 2022

Potential Role of CXCR4 Targeting in the Context of Radiotherapy and Immunotherapy of Cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30622535%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

1 reference

20 November 2019

1 reference

15 December 2019

2 references

9 September 2020

immunological antineoplastic agent

2 references

5 November 2020

3 May 2021

1 reference

8 February 2021

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30622535%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

author name string

Franziska Eckert

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30622535%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

Karin Schilbach

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30622535%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

Lukas Klumpp

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30622535%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

Lilia Bardoscia

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30622535%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

Efe Cumhur Sezgin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30622535%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

Matthias Schwab

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30622535%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

Stephan M Huber

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30622535%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

language of work or name

English

0 references

publication date

21 December 2018

8 references

20 November 2019

15 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30622535%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

28 May 2020

5 November 2020

8 February 2021

3 May 2021

25 July 2022

Frontiers in Immunology

9 references

20 November 2019

15 December 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30622535%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

28 May 2020

9 September 2020

5 November 2020

8 February 2021

3 May 2021

25 July 2022

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30622535%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

page(s)

3018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30622535%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

18 April 2020

copyright license

7 references

20 November 2019

15 December 2019

28 May 2020

5 November 2020

8 February 2021

3 May 2021

Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1

25 July 2022

cites work

1 reference

12 December 2020

Effects of irradiation on the expression of major histocompatibility complex class I antigen and adhesion costimulation molecules ICAM-1 in human cervical cancer

1 reference

12 December 2020

The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1.

1 reference

12 December 2020

Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development

1 reference

12 December 2020

Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice

1 reference

12 December 2020

CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells

1 reference

12 December 2020

Involvement of chemokine receptors in breast cancer metastasis

1 reference

12 December 2020

Stromal-derived factor 1 inhibits the cycling of very primitive human hematopoietic cells in vitro and in NOD/SCID mice

1 reference

12 December 2020

Combination of T-cell therapy and trigger of inflammation induces remodeling of the vasculature and tumor eradication.

1 reference

12 December 2020

Increase of regulatory T cells in the peripheral blood of cancer patients.

1 reference

12 December 2020

Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist

1 reference

12 December 2020

Modulation of tryptophan catabolism by regulatory T cells.

1 reference

12 December 2020

Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma

1 reference

12 December 2020

Stromal cell-derived factor 1-mediated CXCR4 signaling in rat and human cortical neural progenitor cells

1 reference

12 December 2020

Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules

1 reference

12 December 2020

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

12 December 2020

The chemokine receptor CXCR4 is regulated by DNA methylation in pancreatic cancer.

1 reference

12 December 2020

Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells.

1 reference

12 December 2020

T cell costimulation by chemokine receptors

1 reference

12 December 2020

Expression of CXCR4 and its down-regulation by IFN-gamma in head and neck squamous cell carcinoma

1 reference

12 December 2020

Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist

1 reference

12 December 2020

SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells

1 reference

12 December 2020

Activation of chemokine receptor CXCR4 in malignant glioma cells promotes the production of vascular endothelial growth factor

1 reference

12 December 2020

CXCL12 expression is predictive of a shorter time to tumor progression in low-grade glioma: a single-institution study in 50 patients.

1 reference

12 December 2020

SDF-1/CXCL12 enhances survival and chemotaxis of murine embryonic stem cells and production of primitive and definitive hematopoietic progenitor cells

1 reference

12 December 2020

CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer

1 reference

12 December 2020

Murine B16 melanomas expressing high levels of the chemokine stromal-derived factor-1/CXCL12 induce tumor-specific T cell chemorepulsion and escape from immune control

1 reference

12 December 2020

Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy

1 reference

12 December 2020

Prognostic value of CXCL12 expression in 40 low-grade oligodendrogliomas and oligoastrocytomas.

1 reference

12 December 2020

Irradiation and hypoxia promote homing of haematopoietic progenitor cells towards gliomas by TGF-beta-dependent HIF-1alpha-mediated induction of CXCL12.

1 reference

12 December 2020

Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype.

1 reference

12 December 2020

Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes.

1 reference

12 December 2020

Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion

1 reference

12 December 2020

Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

1 reference

12 December 2020

Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches

1 reference

12 December 2020

Regulation of HIF-1alpha stability through S-nitrosylation

1 reference

12 December 2020

Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression.

1 reference

12 December 2020

Multiple-dose escalation study of the safety, pharmacokinetics, and biologic activity of oral AMD070, a selective CXCR4 receptor inhibitor, in human subjects

1 reference

12 December 2020

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression

1 reference

12 December 2020

Combination of tumor site-located CTL-associated antigen-4 blockade and systemic regulatory T-cell depletion induces tumor-destructive immune responses.

1 reference

12 December 2020

CXCR4 engagement promotes dendritic cell survival and maturation

1 reference

12 December 2020

CXCL12-CXCR4 engagement is required for migration of cutaneous dendritic cells

1 reference

12 December 2020

Development of plasmacytoid dendritic cells in bone marrow stromal cell niches requires CXCL12-CXCR4 chemokine signaling.

1 reference

12 December 2020

Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival

1 reference

12 December 2020

Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance

1 reference

12 December 2020

Live attenuated Listeria monocytogenes effectively treats hepatic colorectal cancer metastases and is strongly enhanced by depletion of regulatory T cells

1 reference

12 December 2020

Regulatory-T-cell inhibition versus depletion: the right choice in cancer immunotherapy

1 reference

12 December 2020

CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells

1 reference

12 December 2020

The inhibitory cytokine IL-35 contributes to regulatory T-cell function

1 reference

12 December 2020

Differential expression of CXCL12 and CXCR4 during human fetal neural progenitor cell differentiation

1 reference

12 December 2020

Plasma stromal cell-derived factor-1: host derived marker predictive of distant metastasis in breast cancer.

1 reference

12 December 2020

CCL3 and CXCL12 regulate trafficking of mouse bone marrow NK cell subsets

1 reference

12 December 2020

HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion

1 reference

12 December 2020

CXCR4 is required for the quiescence of primitive hematopoietic cells

1 reference

12 December 2020

Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II.

1 reference

12 December 2020

Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction

1 reference

12 December 2020

Hypoxia- and vascular endothelial growth factor-induced stromal cell-derived factor-1alpha/CXCR4 expression in glioblastomas: one plausible explanation of Scherer's structures.

1 reference

12 December 2020

CTLA-4 control over Foxp3+ regulatory T cell function

1 reference

12 December 2020

Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML.

1 reference

12 December 2020

Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100.

1 reference

12 December 2020

Imaging correlates of leukocyte accumulation and CXCR4/CXCL12 in multiple sclerosis

1 reference

12 December 2020

Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death

1 reference

12 December 2020

Stromal cell-derived factor-1 but not its receptor, CXCR4, gene variants increase susceptibility and pathological development of hepatocellular carcinoma.

1 reference

12 December 2020

Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma

1 reference

12 December 2020

Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor?

1 reference

12 December 2020

SDF-1alpha G801A polymorphism predicts lymph node metastasis in stage T3 colorectal cancer

1 reference

12 December 2020

Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.

1 reference

12 December 2020

Multiple antitumor mechanisms downstream of prophylactic regulatory T-cell depletion

1 reference

12 December 2020

Role of Radiation-induced TGF-beta Signaling in Cancer Therapy

1 reference

12 December 2020

The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects

1 reference

12 December 2020

CXCL12-induced glioblastoma cell migration requires intermediate conductance Ca2+-activated K+ channel activity

1 reference

12 December 2020

Migration of engrafted neural stem cells is mediated by CXCL12 signaling through CXCR4 in a viral model of multiple sclerosis

1 reference

12 December 2020

Recruitment of myeloid but not endothelial precursor cells facilitates tumor regrowth after local irradiation

1 reference

12 December 2020

Low-dose radiation augments vasculogenesis signaling through HIF-1-dependent and -independent SDF-1 induction.

1 reference

12 December 2020

Dysregulated expression of CXCR4/CXCL12 in subsets of patients with systemic lupus erythematosus

1 reference

12 December 2020

Loss of Cxcl12/Sdf-1 in adult mice decreases the quiescent state of hematopoietic stem/progenitor cells and alters the pattern of hematopoietic regeneration after myelosuppression

1 reference

12 December 2020

Conditional regulatory T-cell depletion releases adaptive immunity preventing carcinogenesis and suppressing established tumor growth.

1 reference

12 December 2020

The recruitment of exogenous endothelial progenitor cells in lung tumor model of nude mice

1 reference

12 December 2020

Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers.

1 reference

12 December 2020

Glioblastoma stem-like cells give rise to tumour endothelium.

1 reference

12 December 2020

Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells.

1 reference

12 December 2020

CXCR4 antagonist 4F-benzoyl-TN14003 inhibits leukemia and multiple myeloma tumor growth

1 reference

12 December 2020

Patterns of progression in malignant glioma following anti-VEGF therapy: perceptions and evidence

1 reference

12 December 2020

CXCL12 G801A polymorphism is associated with an increased risk of benign salivary gland tumors in the Chinese population

1 reference

12 December 2020

CXCL12 (SDF1alpha)-CXCR4/CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies?

1 reference

12 December 2020

Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4

1 reference

12 December 2020

SNP rs1801157 significantly correlates with distant metastasis in CXCL12 expressing esophagogastric cancer

1 reference

12 December 2020

The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling.

1 reference

12 December 2020

CXCL12/CXCR4 blockade induces multimodal antitumor effects that prolong survival in an immunocompetent mouse model of ovarian cancer.

1 reference

12 December 2020

Intratumoural level of SDF-1 correlates with survival in head and neck squamous cell carcinoma

1 reference

12 December 2020

PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment

1 reference

12 December 2020

Epigenetic changes of CXCR4 and its ligand CXCL12 as prognostic factors for sporadic breast cancer

1 reference

12 December 2020

CXCR4 and vascular cell adhesion molecule 1 are key chemokine/adhesion receptors in the migration of cytokine-activated T cells

1 reference

12 December 2020

Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells

1 reference

12 December 2020

Immunologic correlates of the abscopal effect in a patient with melanoma

1 reference

12 December 2020

CXCL12 mediates trophic interactions between endothelial and tumor cells in glioblastoma

1 reference

12 December 2020

The brain microenvironment preferentially enhances the radioresistance of CD133(+) glioblastoma stem-like cells

1 reference

12 December 2020

Novel biomarkers and therapeutic targets for optimizing the therapeutic management of melanomas

1 reference

12 December 2020

Radiation-induced reprogramming of breast cancer cells

1 reference

12 December 2020

A rare fraction of drug-resistant follicular lymphoma cancer stem cells interacts with follicular dendritic cells to maintain tumourigenic potential

1 reference

12 December 2020

A review on CXCR4/CXCL12 axis in oncology: no place to hide.

1 reference

12 December 2020

CXCL12, CXCR4 and IFNγ genes expression: implications for proinflammatory microenvironment of breast cancer.

1 reference

12 December 2020

Immunogenic tumor cell death induced by chemoradiotherapy in patients with esophageal squamous cell carcinoma

1 reference

12 December 2020

Plerixafor, a CXCR4 antagonist, mitigates skin radiation-induced injury in mice

1 reference

12 December 2020

CXCR4-positive subset of glioma is enriched for cancer stem cells.

1 reference

12 December 2020

Association between SDF1-3'A or CXCR4 gene polymorphisms with predisposition to and clinicopathological characteristics of prostate cancer with or without metastases.

1 reference

12 December 2020

Involvement of CXCR4 chemokine receptor in metastastic HER2-positive esophageal cancer

1 reference

12 December 2020

Radiation as an immunological adjuvant: current evidence on dose and fractionation.

1 reference

12 December 2020

Human prostate tumor antigen-specific CD8+ regulatory T cells are inhibited by CTLA-4 or IL-35 blockade

1 reference

12 December 2020

Functional effects of SDF-1α on a CD44(+) CXCR4(+) squamous cell carcinoma cell line as a model for interactions in the cancer stem cell niche

1 reference

12 December 2020

DNA double strand break repair: a radiation perspective

1 reference

12 December 2020

Tumor-derived IL-35 promotes tumor growth by enhancing myeloid cell accumulation and angiogenesis

1 reference

12 December 2020

Differential chemotactic receptor requirements for NK cell subset trafficking into bone marrow.

1 reference

12 December 2020

Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth.

1 reference

12 December 2020

Combination of vessel-targeting agents and fractionated radiation therapy: the role of the SDF-1/CXCR4 pathway

1 reference

12 December 2020

Mechanisms of evasive resistance to anti-VEGF therapy in glioblastoma

1 reference

12 December 2020

Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling

1 reference

12 December 2020

The CXCR4 mutations in WHIM syndrome impair the stability of the T-cell immunologic synapse

1 reference

12 December 2020

SLAM family markers resolve functionally distinct subpopulations of hematopoietic stem cells and multipotent progenitors

1 reference

12 December 2020

Molecular mechanisms of ATP secretion during immunogenic cell death

1 reference

12 December 2020

Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis.

1 reference

12 December 2020

Radiation therapy-induced tumor invasiveness is associated with SDF-1-regulated macrophage mobilization and vasculogenesis

1 reference

12 December 2020

Disrupting the CXCL12/CXCR4 axis disturbs the characteristics of glioblastoma stem-like cells of rat RG2 glioblastoma

1 reference

12 December 2020

Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies

1 reference

12 December 2020

Association of CXCL12 and CXCR4 gene polymorphisms with the susceptibility and prognosis of renal cell carcinoma

1 reference

12 December 2020

Preclinical development of a novel class of CXCR4 antagonist impairing solid tumors growth and metastases

1 reference

12 December 2020

The novel CXCR4 antagonist POL5551 mobilizes hematopoietic stem and progenitor cells with greater efficiency than Plerixafor.

1 reference

12 December 2020

Inhibition of CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity.

1 reference

12 December 2020

Physiology and pharmacology of plerixafor

1 reference

12 December 2020

Inhibition of the CXCL12/CXCR4-axis as preventive therapy for radiation-induced pulmonary fibrosis

1 reference

12 December 2020

Blockade of SDF-1 after irradiation inhibits tumor recurrences of autochthonous brain tumors in rats

1 reference

12 December 2020

Induction of a tumor-metastasis-receptive microenvironment as an unwanted and underestimated side effect of treatment by chemotherapy or radiotherapy

1 reference

12 December 2020

Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice.

1 reference

12 December 2020

Radiation-induced immunogenic modulation of tumor enhances antigen processing and calreticulin exposure, resulting in enhanced T-cell killing

1 reference

12 December 2020

Norm- and hypo-fractionated radiotherapy is capable of activating human dendritic cells

1 reference

12 December 2020

CXCR4 as biomarker for radioresistant cancer stem cells

1 reference

12 December 2020

HIF-α/MIF and NF-κB/IL-6 axes contribute to the recruitment of CD11b+Gr-1+ myeloid cells in hypoxic microenvironment of HNSCC.

1 reference

12 December 2020

Possible association between stem-like hallmark and radioresistance in human cervical carcinoma cells

1 reference

12 December 2020

Gr-1+CD11b+ cells facilitate Lewis lung cancer recurrence by enhancing neovasculature after local irradiation

1 reference

12 December 2020

Cutting edge: CXCR4 is critical for CD8+ memory T cell homeostatic self-renewal but not rechallenge self-renewal

1 reference

12 December 2020

Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death

1 reference

12 December 2020

Adult mouse subventricular zones stimulate glioblastoma stem cells specific invasion through CXCL12/CXCR4 signaling

1 reference

12 December 2020

mRNA-based vaccines synergize with radiation therapy to eradicate established tumors

1 reference

12 December 2020

CXCR4 inhibition enhances radiosensitivity, while inducing cancer cell mobilization in a prostate cancer mouse model

1 reference

12 December 2020

Combined VEGF and CXCR4 antagonism targets the GBM stem cell population and synergistically improves survival in an intracranial mouse model of glioblastoma

1 reference

12 December 2020

Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer

1 reference

12 December 2020

Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

1 reference

12 December 2020

Radiotherapy and immunogenic cell death

1 reference

12 December 2020

Combination of radiotherapy and immune checkpoint inhibitors

1 reference

12 December 2020

Intrinsic TGF-β2-triggered SDF-1-CXCR4 signaling axis is crucial for drug resistance and a slow-cycling state in bone marrow-disseminated tumor cells

1 reference

12 December 2020

CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice

1 reference

12 December 2020

Radiotherapy combined with the immunocytokine L19-IL2 provides long-lasting antitumor effects

1 reference

12 December 2020

VEGFR inhibitors upregulate CXCR4 in VEGF receptor-expressing glioblastoma in a TGFβR signaling-dependent manner

1 reference

12 December 2020

Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer

1 reference

12 December 2020

Synergy of Radiotherapy and a Cancer Vaccine for the Treatment of HPV-Associated Head and Neck Cancer

1 reference

12 December 2020

Hypoxia-inducible factor 1α (HIF-1α) and reactive oxygen species (ROS) mediates radiation-induced invasiveness through the SDF-1α/CXCR4 pathway in non-small cell lung carcinoma cells

1 reference

12 December 2020

TGFβ Is a Master Regulator of Radiation Therapy-Induced Antitumor Immunity

1 reference

12 December 2020

Discovery and characterization of an endogenous CXCR4 antagonist

1 reference

12 December 2020

Radiotherapy combined with immune checkpoint blockade immunotherapy: Achievements and challenges

1 reference

12 December 2020

CXCL12-Producing Vascular Endothelial Niches Control Acute T Cell Leukemia Maintenance

1 reference

12 December 2020

CXCR4 Is Required for Leukemia-Initiating Cell Activity in T Cell Acute Lymphoblastic Leukemia.

1 reference

12 December 2020

Cancer-targeted IL-12 controls human rhabdomyosarcoma by senescence induction and myogenic differentiation

1 reference

12 December 2020

Mesenchymal stem cells regulate melanoma cancer cells extravasation to bone and liver at their perivascular niche

1 reference

12 December 2020

CXCL12 and CXCR4 as predictive biomarkers of glioma recurrence pattern after total resection.

1 reference

12 December 2020

CXCR4 and Glioblastoma

1 reference

12 December 2020

CDKN1A regulates Langerhans cell survival and promotes Treg cell generation upon exposure to ionizing irradiation

1 reference

12 December 2020

Dendritic Cell-Induced Th1 and Th17 Cell Differentiation for Cancer Therapy

1 reference

12 December 2020

Prognostic value of CXCL12 and CXCR4 in inoperable head and neck squamous cell carcinoma

1 reference

12 December 2020

Immunogenic cell death.

1 reference

12 December 2020

Additional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in people with malignant lymphoma or multiple myeloma

1 reference

12 December 2020

CXCL12 genetic variants as prognostic markers in nasopharyngeal carcinoma

1 reference

12 December 2020

Paving the Road to Tumor Development and Spreading: Myeloid-Derived Suppressor Cells are Ruling the Fate

1 reference

12 December 2020

Plerixafor for stem cell mobilization: the current status

1 reference

12 December 2020

Mist1 Expressing Gastric Stem Cells Maintain the Normal and Neoplastic Gastric Epithelium and Are Supported by a Perivascular Stem Cell Niche.

1 reference

12 December 2020

Ulocuplumab (BMS-936564 / MDX1338): a fully human anti-CXCR4 antibody induces cell death in chronic lymphocytic leukemia mediated through a reactive oxygen species-dependent pathway

1 reference

12 December 2020

Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells

1 reference

12 December 2020

Effects of radiation on T regulatory cells in normal states and cancer: mechanisms and clinical implications

1 reference

12 December 2020

Interleukin-35 Limits Anti-Tumor Immunity

1 reference

12 December 2020

BK K+ channel blockade inhibits radiation-induced migration/brain infiltration of glioblastoma cells.

1 reference

12 December 2020

Key role of MEK/ERK pathway in sustaining tumorigenicity and in vitro radioresistance of embryonal rhabdomyosarcoma stem-like cell population.

1 reference

12 December 2020

Mesenchymal stem cells generate pericytes to promote tumor recurrence via vasculogenesis after stereotactic body radiation therapy.

1 reference

12 December 2020

EphA1 activation promotes the homing of endothelial progenitor cells to hepatocellular carcinoma for tumor neovascularization through the SDF-1/CXCR4 signaling pathway

1 reference

12 December 2020

Human macrophages induce CD4(+)Foxp3(+) regulatory T cells via binding and re-release of TGF-β.

1 reference

12 December 2020

Plerixafor is safe and efficacious for mobilization of peripheral blood stem cells in pediatric patients

1 reference

12 December 2020

Evidence that high-migration drug-surviving MOLT4 leukemia cells exhibit cancer stem cell-like properties

1 reference

12 December 2020

CXCL12 mediates glioblastoma resistance to radiotherapy in the subventricular zone

1 reference

12 December 2020

Enhanced binding of necrosis-targeting immunocytokine NHS-IL12 after local tumour irradiation in murine xenograft models.

1 reference

12 December 2020

Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells

1 reference

12 December 2020

SDF1 Polymorphisms Influence Outcome in Patients with Symptomatic Cardiovascular Disease

1 reference

12 December 2020

Plerixafor Improves Primary Tumor Response and Reduces Metastases in Cervical Cancer Treated with Radio-Chemotherapy.

1 reference

12 December 2020

Trial Watch: Immunotherapy plus radiation therapy for oncological indications

1 reference

12 December 2020

Interstitial flow differentially increases patient-derived glioblastoma stem cell invasion via CXCR4, CXCL12, and CD44-mediated mechanisms.

1 reference

12 December 2020

Radiation promotes epithelial-to-mesenchymal transition and invasion of pancreatic cancer cell by activating carcinoma-associated fibroblasts

1 reference

12 December 2020

CXCR4 increases in-vivo glioma perivascular invasion, and reduces radiation induced apoptosis: A genetic knockdown study.

1 reference

12 December 2020

Significant Role(s) of CXCL12 and the SDF-1 3'A Genetic Variant in the Pathogenesis of Multiple Sclerosis

1 reference

12 December 2020

SDF-1 Blockade Enhances Anti-VEGF Therapy of Glioblastoma and Can Be Monitored by MRI.

1 reference

12 December 2020

Reprogramming antitumor immunity against chemoresistant ovarian cancer by a CXCR4 antagonist-armed viral oncotherapy

1 reference

12 December 2020

Cathepsin K cleavage of SDF-1α inhibits its chemotactic activity towards glioblastoma stem-like cells.

1 reference

12 December 2020

Mobilization of hematopoietic stem cells with the novel CXCR4 antagonist POL6326 (balixafortide) in healthy volunteers-results of a dose escalation trial

1 reference

12 December 2020

Myeloid-Derived Suppressor Cells

1 reference

12 December 2020

IL-6 Mediates Macrophage Infiltration after Irradiation via Up-regulation of CCL2/CCL5 in Non-small Cell Lung Cancer.

1 reference

12 December 2020

The brain-penetrating CXCR4 antagonist, PRX177561, increases the antitumor effects of bevacizumab and sunitinib in preclinical models of human glioblastoma

1 reference

12 December 2020

Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule Are Induced by Ionizing Radiation on Lymphatic Endothelium

1 reference

12 December 2020

Continuous blockade of CXCR4 results in dramatic mobilization and expansion of hematopoietic stem and progenitor cells

1 reference

12 December 2020

The novel CXCR4 antagonist, PRX177561, reduces tumor cell proliferation and accelerates cancer stem cell differentiation in glioblastoma preclinical models.

1 reference

12 December 2020

Molecular and Microenvironmental Determinants of Glioma Stem-Like Cell Survival and Invasion

1 reference

12 December 2020

Tumor-targeted IL-12 combined with local irradiation leads to systemic tumor control via abscopal effects in vivo.

1 reference

12 December 2020

CXCR4 expression varies significantly among different subtypes of glioblastoma multiforme (GBM) and its low expression or hypermethylation might predict favorable overall survival

1 reference

12 December 2020

Multifaceted C-X-C Chemokine Receptor 4 (CXCR4) Inhibition Interferes with Anti-Vascular Endothelial Growth Factor Therapy-Induced Glioma Dissemination.

1 reference

12 December 2020

KCa3.1 channels and glioblastoma: in vitro studies

1 reference

12 December 2020

Single Dose of the CXCR4 Antagonist BL-8040 Induces Rapid Mobilization for the Collection of Human CD34+ Cells in Healthy Volunteers

1 reference

12 December 2020

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer

1 reference

12 December 2020

TREX1 dictates the immune fate of irradiated cancer cells.

1 reference

12 December 2020

PATZ1 is a new prognostic marker of glioblastoma associated with the stem-like phenotype and enriched in the proneural subtype.

1 reference

12 December 2020

Low-dose photon irradiation induces invasiveness through the SDF-1α/CXCR4 pathway in malignant mesothelioma cells

1 reference

12 December 2020

Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells.

1 reference

12 December 2020

Immune recognition of irradiated cancer cells.

1 reference

12 December 2020

SDF-1/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapy

1 reference

12 December 2020

Targeting CXCR4 reverts the suppressive activity of T-regulatory cells in renal cancer.

1 reference

12 December 2020

In vitro characterization of CD133lo cancer stem cells in Retinoblastoma Y79 cell line

1 reference

12 December 2020

Senescence-associated reprogramming promotes cancer stemness.

1 reference

12 December 2020

CXCR4 antagonist AMD3100 enhances the response of MDA-MB-231 triple-negative breast cancer cells to ionizing radiation.

1 reference

12 December 2020

Abscopal effects of radiotherapy and combined mRNA-based immunotherapy in a syngeneic, OVA-expressing thymoma mouse model.

1 reference

12 December 2020

Targeting the CXCL12/CXCR4 Pathway and Myeloid Cells to Improve Radiation Treatment of Locally Advanced Cervical Cancer.

1 reference

12 December 2020

CXCR4 receptor blockage reduces the contribution of tumor and stromal cells to the metastatic growth in the liver.

1 reference

12 December 2020

Inhibitors of HIF-1α and CXCR4 Mitigate the Development of Radiation Necrosis in Mouse Brain.

1 reference

12 December 2020

Combined modality radiation therapy promotes tolerogenic myeloid cell populations and STAT3-related gene expression in head and neck cancer patients.

1 reference

12 December 2020

Combination Cancer Therapy with Immune Checkpoint Blockade: Mechanisms and Strategies

1 reference

12 December 2020

SDF-1/CXCR4 expression in head and neck cancer and outcome after postoperative radiochemotherapy.

1 reference

12 December 2020

Interleukin 7-expressing fibroblasts promote breast cancer growth through sustenance of tumor cell stemness.

1 reference

12 December 2020

Beyond checkpoint inhibition - Immunotherapeutical strategies in combination with radiation.

1 reference

12 December 2020

Epigenetic Regulation of CXCL12 Plays a Critical Role in Mediating Tumor Progression and the Immune Response In Osteosarcoma

1 reference

12 December 2020

Effect of a novel orally bioavailable CXCR4 inhibitor, AMD070, on the metastasis of oral cancer cells

1 reference

12 December 2020

Current landscape and future of dual anti-CTLA4 and PD-1/PD-L1 blockade immunotherapy in cancer; lessons learned from clinical trials with melanoma and non-small cell lung cancer (NSCLC).

1 reference

12 December 2020

CXCR4-mediated osteosarcoma growth and pulmonary metastasis is suppressed by MicroRNA-613

1 reference

12 December 2020

An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0.

1 reference

12 December 2020

Pancreatic cancer stem cells: features and detection methods

1 reference

12 December 2020

Loss of CXCR4 in Myeloid Cells Enhances Antitumor Immunity and Reduces Melanoma Growth through NK Cell and FASL Mechanisms

1 reference

12 December 2020

Identifiers

DOI

10.3389/FIMMU.2018.03018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30622535%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30622535%20AND%20SRC:MED&resulttype=core&format=json

18 April 2020

PubMed publication ID

30622535

1 reference